Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Back to Ependymoma

Ependymoma — NIH Grants & Funding

Active and recent NIH-funded research on Ependymoma. Data from NIH RePORTER, last 36 months.

MONDO:0016698

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Ependymoma has active NIH research funding with 14 funded grants totaling $13.8M.

14funded grants from NIH

Portfolio: $5.6MCumulative: $13.8M8 active6 completed14 PIs10 institutions

By Research Theme

Basic Science

Translational

Clinical

1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$2.2M

FY22

$3.5M

FY23

$3.6M

FY24

$3.6M

FY25

$882K

FY26

By Funding Mechanism

R01

R21

K08

U01

U54

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Ependymoma. Strongest funded area: Basic Science. Largest gap: Translational / Drug Development.

Translational / Drug DevelopmentFunded, Few Publications

2 funded grants in Translational / Drug Development but only 1 related publication found for ependymoma. This may indicate early-stage research that hasn't yet produced published results.

Adjacent Research(8 grants)

These grants mention Ependymoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(8)

OtherZIACompleted

CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures

Gilbert, Mark·DIVISION OF BASIC SCIENCES - NCI

$4,449,073 (FY2024)

NIH RePORTER

OtherU24Active

Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights

Zhang, Bing·BAYLOR COLLEGE OF MEDICINE·HOUSTON, TX

$640,150 (FY2025)

NIH RePORTER

OtherZIACompleted

Rare Central Nervous System Cancers Initiative

Gilbert, Mark·DIVISION OF BASIC SCIENCES - NCI

$494,832 (FY2024)

NIH RePORTER

OtherR01Completed

Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets

KISSIL, JOSEPH·H. LEE MOFFITT CANCER CTR & RES INST·TAMPA, FL

$395,445 (FY2024)

NIH RePORTER

OtherU01Completed

In vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models

Li, Xiaonan·LURIE CHILDREN'S HOSPITAL OF CHICAGO·CHICAGO, IL

$237,825 (FY2025)

NIH RePORTER

OtherUM1Completed

Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors

Dunkel, Ira et al.·ST. JUDE CHILDREN'S RESEARCH HOSPITAL·MEMPHIS, TN

$3,793,439 (FY2025)

NIH RePORTER

OtherR01Completed

Structure and function of a novel population of regenerating ependymal cells

Alvarez-Buylla, Arturo·UNIVERSITY OF CALIFORNIA, SAN FRANCISCO·SAN FRANCISCO, CA

$420,055 (FY2024)

NIH RePORTER

OtherF31Completed

Germline Structural Variant Identification and Functional Determination in Childhood Cancer

Hirschi, Owen·BAYLOR COLLEGE OF MEDICINE·HOUSTON, TX

$45,289 (FY2023)

NIH RePORTER

NIH Grants & Funding for Ependymoma | Kisho | Kisho

Kisho

Ependymoma — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(8 grants)

Other(8)

CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures

Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights

Rare Central Nervous System Cancers Initiative

Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets

In vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models

Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors

Structure and function of a novel population of regenerating ependymal cells

Germline Structural Variant Identification and Functional Determination in Childhood Cancer

Top Funded Institutions

Top Principal Investigators